Impacts of Pharmaceutical Pollution on Communities and Environment in India
As part of our engagement with pharmaceutical companies and their supply chain management in India and a follow-up to the video about Nordea’s visit to Hyderabad and Visakhapatnam in April 2015, we commissioned an on-the-ground investigation in Hyderabad and Visakhaptanam in early 2016. The resulting report documents and show local impacts of drug pollution and severe contamination of waterways and agricultural lands. Again, the evidence shows that the situation is very serious. The effluent treatments systems set up are inefficient and there is systematic dumping of chemical effluent in rivers, lakes and groundwater by the pharmaceutical sector.
The report draws links between polluting manufacturers and some of the large multinational pharmaceutical companies they have dealings with. But the report also concludes that the lack of transparency in pharmaceutical supply chains makes it almost impossible to map the journey of a pharmaceutical product from factory to pharmacy shelf.
We will continue our dialogue with the pharmaceutical companies.
Download the report here (pdf, 10 MB).
Other Responsible investment news
Unless we learn from the mistakes of the past and start focusing on more than short-term gains, our financial myopia could lead to losses, bankruptcies and m...
Our work Responsible investment
It is our pleasure to present the Nordea Asset Management Annual Responsible Investment Report for 2016.
Nordea Asset Management has just been acknowledged for the on-going work with ESG and responsible investments.
Responsibility Responsible investment Responsible business
Nordea’s team for Responsible Investments recommends an exclusion of the three companies behind the Dakota Access Pipeline.
After years of consistent and dedicated work with ESG and responsible investments, Nordea Asset Management is considered a pioneer within this area.